Edward C. McCarron

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky et al. · The Lancet Oncology · 2018 · 158 citations · Full text

Postmenopausal Breast Cancer, Oncology, Breast Oncology +12

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30

Hanna Bandos, Joy Melnikow, Donna R. Rivera et al. · JNCI Journal of the National Cancer Institute · 2017 · 124 citations · Full text

Surgical Management and Outcome in Primary Adenocarcinoma of the Small Bowel

Shefali Agrawal, Edward C. McCarron, John F. Gibbs et al. · Annals of Surgical Oncology · 2007 · 89 citations

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +9

Randomized clinical trial to determine the effect of nasogastric drainage on tracheal acid aspiration following oesophagectomy

Michael Shackcloth, Edward C. McCarron, John Kendall et al. · British journal of surgery · 2006 · 53 citations · Full text